Lymphatic System Neoplasm Clinical Trials

60 recruitingLast updated: July 26, 2026

There are 60 actively recruiting lymphatic system neoplasm clinical trials across 3 countries. Studies span Not Applicable, Phase 2, Phase 1, Early Phase 1, Phase 3. Top locations include Rochester, Minnesota, United States, Jacksonville, Florida, United States, Seattle, Washington, United States. Updated daily from ClinicalTrials.gov.


Lymphatic System Neoplasm Trials at a Glance

60 actively recruiting trials for lymphatic system neoplasm are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Not Applicable with 26 trials, with the heaviest enrollment activity in Rochester, Jacksonville, and Seattle. Lead sponsors running lymphatic system neoplasm studies include Mayo Clinic, City of Hope Medical Center, and Fred Hutchinson Cancer Center.

Browse lymphatic system neoplasm trials by phase

Treatments under study

About Lymphatic System Neoplasm Clinical Trials

Looking for clinical trials for Lymphatic System Neoplasm? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Lymphatic System Neoplasm trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Lymphatic System Neoplasm clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 60 trials

Recruiting
Not Applicable

Dental Cleaning to Prevent Chronic Graft-Versus-Host Disease

Acute Graft Versus Host DiseaseHematopoietic and Lymphatic System NeoplasmChronic Graft Versus Host Disease
Fred Hutchinson Cancer Center45 enrolled1 locationNCT07535008
Recruiting

Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation

Hematopoietic and Lymphatic System NeoplasmMalignant Solid NeoplasmGraft-Versus-Host Disease
City of Hope Medical Center75 enrolled1 locationNCT07235501
Recruiting
Phase 2

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

Hematopoietic and Lymphatic System NeoplasmAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+7 more
Fred Hutchinson Cancer Center54 enrolled1 locationNCT06013423
Recruiting
Phase 3

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Children's Oncology Group60 enrolled205 locationsNCT06513962
Recruiting
Phase 1Phase 2

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

Hematopoietic and Lymphatic System NeoplasmMetastatic Malignant Solid NeoplasmStage IV Colorectal Cancer AJCC v8+4 more
National Cancer Institute (NCI)42 enrolled23 locationsNCT05691491
Recruiting

Quality of End-of-Life Care for Children With Cancer

Childhood Malignant Solid NeoplasmChildhood Hematopoietic and Lymphatic System Neoplasm
Children's Oncology Group2,425 enrolled15 locationsNCT07412002
Recruiting
Not Applicable

Solution-Focused Brief Therapy for Support of Psychological Distress in Adolescent and Young Adult Cancer Survivors

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
University of Michigan Rogel Cancer Center60 enrolled1 locationNCT06941324
Recruiting
Phase 1

Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation

Hematopoietic and Lymphatic System Neoplasm
City of Hope Medical Center42 enrolled1 locationNCT07025538
Recruiting
Phase 1

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

Hematopoietic and Lymphatic System NeoplasmAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+9 more
City of Hope Medical Center46 enrolled3 locationsNCT07020533
Recruiting

Evaluation of a Novel Auto Segmentation Algorithm for Normal Structure Delineation in Radiation Treatment Planning

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Mayo Clinic200 enrolled7 locationsNCT06200116
Recruiting

Impact of Physician Behavior on Cancer Distress

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Mayo Clinic5,000 enrolled1 locationNCT07325006
Recruiting
Not Applicable

Comparing the Impact of Four Types of Meditation Practices for Relaxation in Cancer Survivors

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
City of Hope Medical Center44 enrolled2 locationsNCT06500377
Recruiting
Not Applicable

Virtual Reality for Symptom Management in Patients Undergoing Hematopoietic Stem Cell Transplantation

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Roswell Park Cancer Institute28 enrolled1 locationNCT06798701
Recruiting

Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology

Malignant Solid NeoplasmLymphatic System NeoplasmHematopoietic Neoplasms
Wake Forest University Health Sciences3,000 enrolled1 locationNCT06897137
Recruiting
Phase 2

Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome

Hematopoietic and Lymphatic System Neoplasm
OHSU Knight Cancer Institute26 enrolled1 locationNCT06895473
Recruiting
Not Applicable

A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment

Hematopoietic and Lymphatic System NeoplasmMalignant Solid NeoplasmChemotherapy Induced Peripheral Neuropathy
University of Michigan Rogel Cancer Center50 enrolled1 locationNCT07365007
Recruiting
Not Applicable

Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
NRG Oncology600 enrolled34 locationsNCT06279013
Recruiting

Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Mayo Clinic30 enrolled1 locationNCT06640010
Recruiting
Not Applicable

A Mindfulness-Based Stress Reduction Program for Improving Mental Health Outcomes for Underserved Cancer Patients in Minnesota

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Mayo Clinic45 enrolled1 locationNCT07291011
Recruiting
Not Applicable

Virtual Reality Viewing of Unaltered Streetscape Versus Digitally Manipulated Opposite Streetscape to Assess Psychosocial Response in Participants

Hematopoietic and Lymphatic System NeoplasmMalignant Solid NeoplasmPsychiatric Disorder
Ohio State University Comprehensive Cancer Center32 enrolled1 locationNCT07216534